NCT02034656View on ClinicalTrials.gov

Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)

UnknownOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

March 31, 2014

Study Completion Date

November 30, 2014

Conditions

Chronic Myeloid Leukemia or Ph Positive ALL

Trial Locations (1)

137-701

RECRUITING

Seoul St. Mary's Hospital, Seoul

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Seoul St. Mary's Hospital

OTHER